Multiplex FRET Imaging of Kinase-Epigenome Interregulations in Live Cancer Cells
Multiplex FRET Imaging of Kinase-Epigenome Interregulations in Live Cancer Cells
批准号:
9281530
负责人:
Yingxiao Wang
金额:
$37.68万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-08-10 至 2020-07-31
关键词:
Adenocarcinoma CellAntineoplastic AgentsBindingBiosensorCalibrationCancer BiologyCell LineCellsClinicalClustered Regularly Interspaced Short Palindromic RepeatsCodeColorCoupledCultured CellsDetectionDevelopmentDirected Molecular EvolutionDrug resistanceEngineeringEpigenetic ProcessEventFluorescence Resonance Energy TransferFocal Adhesion Kinase 1FoundationsGene ExpressionGenetic EngineeringGenomeGenome engineeringGoalsHeterogeneityHistonesImageImage AnalysisImageryImaging DeviceIndividualLeadLibrariesLifeMalignant NeoplasmsMalignant neoplasm of pancreasMapsMediatingMethodsModelingModificationMolecularMolecular ProfilingMonitorOrganoidsOutcomePancreatic Ductal AdenocarcinomaPharmaceutical PreparationsPharmacologyPharmacotherapyPharmacy (field)PhosphotransferasesPreclinical Drug EvaluationProtamine KinaseProtein EngineeringProtein Tyrosine KinaseReagentRecurrent diseaseRegulationResistanceSignal TransductionTechnologyTherapeuticTyrosine Kinase InhibitorWorkanticancer researchbasecancer cellcancer therapycancer typecellular imagingchemotherapyclinical applicationdesigndosagedrug efficacyepigenomeexperiencegemcitabinehistone methylationimaging modalityimaging systemindexinginhibitor/antagonistkinase inhibitorlive cell imagingnovel therapeuticspancreatic cancer cellsresponsescreeningspatiotemporalsuccesstherapy outcometooltumor progression
中文摘要
活体癌细胞中激酶-表观基因组相互调控的多重FRET成像
激酶抑制剂已被应用于缓解胰腺癌的发展。然而,适应性表观遗传学
包括组蛋白调节在内的反应可以导致大规模基因表达的改变,这可以
最终导致癌细胞的异质性耐药反应和危及生命的肿瘤复发
疾病。在目前阶段,酪氨酸激酶活性如何动态地与
表观遗传组蛋白调节以确定癌细胞对药物治疗的反应。因此,调查
而操纵组蛋白调节和密码的调节在癌症治疗中具有重要意义
和药物筛查。在这个提案中,我们将利用定向进化和高内容筛选的力量
方法系统研制动态荧光共振能量转移(FRET)生物传感器
监测和定量单细胞中关键的组蛋白甲基化(H3K4、H3K9、H3K27)。我们还将
应用此方法优化粘着斑激酶(FAK)FRET生物传感器用于FAK的可视化
激活酶活性。与我们优化的现有Src FRET生物传感器一起,这些生物传感器将被
使用CRIPSR整合到胰腺癌细胞的基因组中,以最小化信号的异质性
跨越不同的单个细胞。我们将进一步加入新的FRET对,这些FRET对发出与
流行的FRET对(CFP和YFP),用于同时监测同一活细胞中的两个不同信号,例如一个
组蛋白甲基化和一种激酶的激活。使用共同的分子信号作为跨不同
单个细胞,这些关键的分子事件将与相关的FRET成像方法一起映射
(CFIM)是我们实验室开发的,用于生成动态组-表观组相互作用的动态图景。
药理试剂将被用来研究它们对这些分子动态格局的影响
相互作用和适应性表观遗传反应。然后我们将把这些多重分子图谱关联到
在这些药理试剂下的癌症转归,并因此提供量化的多重指数
在单细胞水平上评估药物疗效,目标是将耐药性降至最低。三个具体目标是
据此提出:(1)开发和优化组蛋白甲基化和酪氨酸激酶FRET生物传感器;(2)
应用CRISPR将FRET生物传感器基因工程导入胰腺癌细胞系用于校准
在单细胞中的抑制效果;(3)组蛋白甲基化和激酶活性的多重成像
用于评估对激酶抑制的适应性表观遗传反应的PDAC细胞。鉴于其重要性和紧迫性
需要新的成像工具来研究癌细胞中的动态组-表观组连接,开发了FRET
生物传感器和成像系统应该为解开癌症的分子网络提供强有力的手段
生物学,并允许以最小的耐药性进行药物筛选的多路和高通量平台。因此,
该项目的成功将为癌症研究和研究领域贡献变革性的使能技术
药剂学,朝着根除胰腺癌的最终目标前进。
英文摘要
Multiplex FRET Imaging of Kinase-Epigenome Interregulations in Live Cancer Cells
Kinase inhibitors have been applied to mitigate pancreatic cancer development. However, adaptive epigenetic
responses including histone modulations can lead to the alteration of large scale gene expressions which can
ultimately result in heterogeneous drug resistant responses of cancer cells and life-threatening relapse of
diseases. At the current stage, it remains unclear how tyrosine kinase activities are dynamically coupled with
epigenetic histone modulations to determine cancer cell responses upon drug treatment. Therefore, investigating
and manipulating the regulation of histone modulations and codes have crucial implications in cancer treatment
and drug screening. In this proposal, we will harness the power of directed evolution and high-content screening
methods to systematically develop fluorescence resonance energy transfer (FRET) biosensors for the dynamic
monitoring and quantification of crucial histone methylations (H3K4, H3K9, H3K27) in single cells. We will also
apply this approach to optimize a focal adhesion kinase (FAK) FRET biosensor for the visualization of FAK
kinase activity. Together with an existing Src FRET biosensor optimized by us, these biosensors will be
incorporated into the genome of pancreatic cancer cells using CRIPSR to minimize the heterogeneity of signals
across different individual cells. We will further incorporate new FRET pairs emitting colors distinct from the
popular FRET pair (CFP and YFP) to simultaneously monitor two different signals in the same live cell, e.g. one
histone methylation and one kinase activation. Using a common molecular signal as a reference across different
individual cells, these crucial molecular events will be mapped together with correlative FRET imaging method
(CFIM) developed in our labs to generate dynamic landscapes of kinome-epigenome interactions.
Pharmacological reagents will be applied to study their impact on these dynamic landscape of molecular
interactions and adaptive epigenetic responses. We will then correlate these multiplex molecular profiles to
cancer outcomes under these pharmacological reagents, and hence provide quantified multiplex indices to
evaluate drug efficacy at the single-cell level with the goal of minimizing drug resistance. Three specific aims are
accordingly proposed: (1) Develop and optimize histone methylation and tyrosine kinase FRET biosensors; (2)
Apply CRISPR to genetically engineer FRET biosensors into pancreatic cancer cell lines for the calibration of
inhibitor efficacy in single cells; (3) Multiplex imaging of histone methylations and kinase activities in the same
PDAC cells for assessing adaptive epigenetic responses upon kinase inhibition. Given the importance and critical
needs of new imaging tools to investigate the kinome-epigenome connection in cancer cells, developed FRET
biosensors and imaging system should provide powerful means to unravel the molecular network for cancer
biology, and allow multiplex and high throughput platform for drug screening with minimal resistance. As such,
the success of the project will contribute transformative enabling technologies to the field of cancer research and
pharmaceutics, toward an ultimate goal of eradicating pancreatic cancers.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Ultrasound-controlled remote activation of CAR T cells for localized tumor immunotherapy
-
批准号:10816252
-
项目类别:
-
资助金额:$45.23万
-
财政年份:2023
-
负责人:Yingxiao Wang
-
依托单位:
Ultrasensitive kinase biosensors for multiplex imaging of coordinated spatiotemporal signaling in cancer-immune interactions
-
批准号:10666398
-
项目类别:
-
资助金额:$63.62万
-
财政年份:2022
-
负责人:Yingxiao Wang
-
依托单位:
Single Cell Tracking of 3D Epigenetic Landscape Evolution During Embryonic Development
-
批准号:10344905
-
项目类别:
-
资助金额:$67.94万
-
财政年份:2022
-
负责人:Yingxiao Wang
-
依托单位:
Ultrasensitive kinase biosensors for multiplex imaging of coordinated spatiotemporal signaling in cancer-immune interactions
-
批准号:10445685
-
项目类别:
-
资助金额:$64.91万
-
财政年份:2022
-
负责人:Yingxiao Wang
-
依托单位:
Single Cell Tracking of 3D Epigenetic Landscape Evolution During Embryonic Development
-
批准号:10581484
-
项目类别:
-
资助金额:$65.24万
-
财政年份:2022
-
负责人:Yingxiao Wang
-
依托单位:
Acoustothermogenetics for Cell Engineering
-
批准号:10631097
-
项目类别:
-
资助金额:$53.77万
-
财政年份:2021
-
负责人:Yingxiao Wang
-
依托单位:
Acoustothermogenetics for Cell Engineering
-
批准号:10413031
-
项目类别:
-
资助金额:$39.98万
-
财政年份:2021
-
负责人:Yingxiao Wang
-
依托单位:
Acoustothermogenetics for Cell Engineering
-
批准号:10825009
-
项目类别:
-
资助金额:$35.33万
-
财政年份:2021
-
负责人:Yingxiao Wang
-
依托单位:
Ultrasound-controlled remote activation of CAR T cells for localized tumor immunotherapy
-
批准号:10447186
-
项目类别:
-
资助金额:$46.38万
-
财政年份:2020
-
负责人:Yingxiao Wang
-
依托单位:
Ultrasound-controlled remote activation of CAR T cells for localized tumor immunotherapy
-
批准号:10263890
-
项目类别:
-
资助金额:$39.57万
-
财政年份:2020
-
负责人:Yingxiao Wang
-
依托单位:
Remote-Control Mechano-Genetics and Epigenetics for Live Cell Manipulation
-
批准号:9765353
-
项目类别:
-
资助金额:$28.88万
-
财政年份:2018
-
负责人:Yingxiao Wang
-
依托单位:
Engineering Machinery Molecules to Visualize and Actuate Immunotherapy
-
批准号:9318987
-
项目类别:
-
资助金额:$16.86万
-
财政年份:2017
-
负责人:Yingxiao Wang
-
依托单位:
A Systematic Approach to Engineer Fyn Kinase Biosensor
-
批准号:8668708
-
项目类别:
-
资助金额:$23.25万
-
财政年份:2012
-
负责人:Yingxiao Wang
-
依托单位:
A Systematic Approach to Engineer Fyn Kinase Biosensor
-
批准号:8728967
-
项目类别:
-
资助金额:$18.79万
-
财政年份:2012
-
负责人:Yingxiao Wang
-
依托单位:
FLIM and FRET for the Visualization of Flow-induced Molecular Hierarchies
-
批准号:8665460
-
项目类别:
-
资助金额:$10.98万
-
财政年份:2011
-
负责人:Yingxiao Wang
-
依托单位:
FLIM and FRET for the Visualization of Flow-induced Molecular Hierarchies
-
批准号:8460536
-
项目类别:
-
资助金额:$10.98万
-
财政年份:2011
-
负责人:Yingxiao Wang
-
依托单位:
FLIM and FRET for the Visualization of Flow-induced Molecular Hierarchies
-
批准号:8320077
-
项目类别:
-
资助金额:$10.98万
-
财政年份:2011
-
负责人:Yingxiao Wang
-
依托单位:
FLIM and FRET for the Visualization of Flow-induced Molecular Hierarchies
-
批准号:8840314
-
项目类别:
-
资助金额:$10.98万
-
财政年份:2011
-
负责人:Yingxiao Wang
-
依托单位:
The Integration of FLIM and FRET for the Visualization of Flow-induced Molecular
-
批准号:8165734
-
项目类别:
-
资助金额:$10.98万
-
财政年份:2011
-
负责人:Yingxiao Wang
-
依托单位:
FRET Imaging of Molecular Hierarchy at Subcellular Levels in Mechanotransduction
-
批准号:8011428
-
项目类别:
-
资助金额:$38.84万
-
财政年份:2010
-
负责人:Yingxiao Wang
-
依托单位:
海外基金